About

Bluesight focuses on improving supply chain processes in the healthcare sector, specifically for hospital pharmacies. The company uses AI and machine learning to analyze data related to the medication lifecycle, providing actionable insights that help hospitals manage their medications more effectively. Their Medication Intelligence™ solutions enhance visibility and predictability in medication management, allowing pharmacies to operate more efficiently, lower medication costs, and ensure compliance and safety. Unlike many competitors, Bluesight specifically targets the needs of hospital pharmacies and has established a strong presence, serving over 1,600 hospitals in the U.S. and Canada. The goal of Bluesight is to optimize pharmacy practices and improve overall healthcare delivery through better medication management.

Simplify's Take

What believers are saying

• Increased RFID adoption aligns with Bluesight's focus on medication management efficiency.
• Thoma Bravo's investment provides resources for Bluesight's expansion and innovation.
• Rebranding to ControlCheck strengthens Bluesight's market positioning in medication management.

What critics are saying

• Kit Check's RFID technology poses competition to Bluesight's market share.
• Thoma Bravo's investment may pressure Bluesight for rapid financial returns.
• Rebranding may cause temporary confusion among Bluesight's existing clients.

What makes Bluesight unique

• Bluesight leverages AI and machine learning for medication lifecycle analytics.
• The company serves over 1,600 hospitals in the U.S. and Canada.
• Bluesight's Medication Intelligence solutions enhance visibility and predictability in medication management.

Help us improve and share your feedback! Did you find this helpful?

YesNo